TRILEPTAL Safety Questions, TRILEPTAL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about TRILEPTAL. Our extensive database of TRILEPTAL adverse events and TRILEPTAL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about TRILEPTAL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




TRILEPTAL Safety Reports

Total TRILEPTAL reports: 438.
TRILEPTAL FDA safety alerts: 2005 .
Reported deaths: 11    Reported hospitalizations: 158.
Take TRILEPTAL Side Effects Survey or Share Your TRILEPTAL Story. Read More Here.

Showing 1-75 of 438 Next >

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Mar 27, 2007. Female patient was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: affect lability, depression, dysgeusia, fear, poisoning. TRILEPTAL dosage: 900 MG, QD. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from BRAZIL on Mar 28, 2007. Female patient, 43 years of age, weighting 205.0 lb, was diagnosed with mood altered and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anxiety, blood pressure decreased, depressed level of consciousness, depression, eating disorder, emotional disorder, fatigue, feeling abnormal. TRILEPTAL dosage: 150 MG, QID. During the same period patient was treated with AMPLICTIL. Patient was hospitalized. Patient recovered.

Health Professional from GERMANY reported TRILEPTAL problem on Mar 30, 2007. Male patient, 29 years of age, was diagnosed with epilepsy, alopecia and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, grand mal convulsion, memory impairment, speech disorder. TRILEPTAL dosage: 600 MG/D. During the same period patient was treated with PROPECIA. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from BRAZIL on Apr 02, 2007. Female patient, 30 years of age, weighting 134.5 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, progesterone abnormal, uterine dilation and curettage. TRILEPTAL dosage: 900 MG/D (0.5-0-1). During the same period patient was treated with METFORMIN. Patient recovered.

Consumer or non-health professional from GERMANY reported TRILEPTAL problem on Apr 02, 2007. Male patient was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, nervous system disorder, personality disorder, suicidal behaviour, suicidal ideation. TRILEPTAL dosage: 600 MG/D. During the same period patient was treated with PANTOZOL, ALENDRONIC ACID, CALCIUM, THEOPHYLLIN RETARD, VALSARTAN AND HYDROCHLOROTHIAZIDE, XIPAMIDE, CARVEDILOL, PREDNISOLONE. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from MEXICO on Apr 04, 2007. Female patient, 16 years of age, was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, intentional overdose, tonic clonic movements, vomiting. TRILEPTAL dosage: 600 MG, BID. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Apr 13, 2007. Male patient, 25 years of age, weighting 200.0 lb, was diagnosed with convulsion, bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: arthralgia. TRILEPTAL dosage: unknown. During the same period patient was treated with LAMICTAL. Patient died on 09/14/2005.

TRILEPTAL problem was reported by a Physician from FRANCE on Apr 05, 2007. Female patient, child 5 years of age, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: conjunctivitis, lymphadenopathy, pyrexia, rash morbilliform. TRILEPTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported TRILEPTAL problem on Apr 09, 2007. Female patient, 73 years of age, weighting 132.3 lb, was diagnosed with bone disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: petit mal epilepsy. TRILEPTAL dosage: 2400 MG/D. During the same period patient was treated with ALENDRONATE, ROCALTROL, FOSAMAX. Patient recovered.

TRILEPTAL problem was reported by a Physician from BRAZIL on Apr 09, 2007. Female patient, 49 years of age, was diagnosed with petit mal epilepsy, neurotransmitter level altered and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abnormal sensation in eye, anxiety, aura, chills, corrective lens user, crying, diplopia, disorientation. TRILEPTAL dosage: 600 MG, TID. During the same period patient was treated with OXCARBAZEPINE, TOPAMAX, RIVOTRIL, PAROXETINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Apr 13, 2007. Female patient, 31 years of age, weighting 122.0 lb, was diagnosed with bipolar disorder, post-traumatic stress disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: pyelonephritis, urinary tract infection, vaginitis bacterial. TRILEPTAL dosage: unknown. During the same period patient was treated with GEODON, LEXAPRO. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from BRAZIL on Apr 11, 2007. Male patient, child 6 years of age, weighting 72.75 lb, was diagnosed with convulsion, hypersensitivity and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal disorder, gastrointestinal infection, pyrexia. TRILEPTAL dosage: 5.5 ML, Q12H. During the same period patient was treated with KETOTIFEN, SINGULAIR. Patient recovered.

Consumer or non-health professional from BRAZIL reported TRILEPTAL problem on Apr 11, 2007. Male patient, child 6 years of age, weighting 72.75 lb, was diagnosed with convulsion, hypersensitivity and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: diarrhoea, gastrointestinal disorder, gastrointestinal infection, pyrexia. TRILEPTAL dosage: 5.5 ML, Q12H. During the same period patient was treated with KETOTIFEN, SINGULAIR. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Female patient, 31 years of age, weighting 122.0 lb, was diagnosed with bipolar disorder, post-traumatic stress disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: pyelonephritis, urinary tract infection, vaginitis bacterial. TRILEPTAL dosage: unknown. During the same period patient was treated with GEODON, LEXAPRO. Patient recovered.

Consumer or non-health professional from GERMANY reported TRILEPTAL problem on Apr 18, 2007. Female patient, child 3 years of age, was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, dysgeusia, treatment noncompliance. TRILEPTAL dosage: 375-0-450 MG/DAY. During the same period patient was treated with LAMICTAL. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from BRAZIL on Apr 18, 2007. Male patient, weighting 158.7 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: alopecia, convulsion, irritability, lip dry, lip haemorrhage, mood altered, nail disorder, nervousness. TRILEPTAL dosage: 300 MG, TID. During the same period patient was treated with TEGRETOL, DEPAKENE. Patient recovered.

Consumer or non-health professional from BRAZIL reported TRILEPTAL problem on Apr 18, 2007. Female patient, 20 years of age, weighting 125.7 lb, was diagnosed with depression and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: cyanosis, depression, diplopia, dizziness, dysstasia, insomnia, malaise, syncope, therapeutic agent toxicity. TRILEPTAL dosage: 300 MG. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from BRAZIL on Apr 19, 2007. Male patient, 57 years of age, weighting 198.4 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, chromaturia, convulsion, jaundice, ocular icterus. TRILEPTAL dosage: 300 MG/DAY. Patient recovered.

Consumer or non-health professional from BRAZIL reported TRILEPTAL problem on Apr 18, 2007. Male patient, 45 years of age, weighting 165.3 lb, was diagnosed with labyrinthitis, depression and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: dizziness, hypoacusis, malaise, ocular discomfort, retching, tinnitus. TRILEPTAL dosage: 300 MG, Q12H. During the same period patient was treated with SERTRALINE HYDROCHLORIDE, PLASIL. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Male patient, 31 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: dyspnoea, rash, throat tightness. TRILEPTAL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Nov 14, 2006. Female patient was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased. TRILEPTAL dosage: unknown. Patient recovered.

TRILEPTAL problem was reported by a Health Professional from UNITED STATES on Jan 09, 2007. Male patient, 50 years of age, weighting 226.9 lb, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fall, feeling abnormal, gait disturbance, gallbladder polyp, lipase increased, pancreatitis acute, rash. TRILEPTAL dosage: 900 MG, BID, ORAL. During the same period patient was treated with EFFEXOR, REMERON, AMBIEN, SEROQUEL. Patient recovered.

Pharmacist from UNITED STATES reported TRILEPTAL problem on Dec 05, 2006. Female patient, 47 years of age, was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, fall, jaw fracture. TRILEPTAL dosage: unknown. During the same period patient was treated with TOPAMAX, ACTONEL, RISPERDAL, BENZTROPINE MESYLATE, DIOVAN HCT. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2006. Male patient was diagnosed with affective disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: dizziness, herpes simplex, nausea, pruritus, pyrexia, rash maculo-papular, scab, skin exfoliation. TRILEPTAL dosage: 300 MG, BID. During the same period patient was treated with EFFEXOR, GABAPENTIN, LISINOPRIL, ATENOLOL, METFORMIN, NASONEX. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on May 04, 2006. Female patient, 33 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, depression, irritability. TRILEPTAL dosage: 1200 MG, QHS, ORAL. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on June 22, 2006. Female patient, 68 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: dizziness, hyponatraemia. TRILEPTAL dosage: 600 MG, BID, ORAL. During the same period patient was treated with NEXIUM, CADUET, SYNTHROID. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on May 16, 2006. Female patient was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: fatigue, hepatic enzyme increased, jaundice, nausea. TRILEPTAL dosage: 300 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from PUERTO RICO on May 11, 2006. Female patient, 50 years of age, weighting 170.0 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: asthenia, hyponatraemia, myalgia, oedema. TRILEPTAL dosage: 300 MG, TID. During the same period patient was treated with WELLBUTRIN, ZYRTEC, PROTONIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on May 16, 2006. Female patient, 45 years of age, was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, hyponatraemia. TRILEPTAL dosage: unknown. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on May 16, 2006. Female patient, 85 years of age, was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, nausea. TRILEPTAL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on May 17, 2006. Male patient, child 7 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. TRILEPTAL dosage: 300 MG, QD. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Health Professional from UNITED STATES on May 19, 2006. Female patient was diagnosed with schizophrenia and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. TRILEPTAL dosage: 900 MG, BID, ORAL. During the same period patient was treated with PROLIXIN. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Aug 03, 2006. Female patient, 14 years of age, weighting 100.1 lb, was diagnosed with convulsion, acne and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, hypopnoea. TRILEPTAL dosage: 900 MG BID ORAL. During the same period patient was treated with MINOCYCLINE. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on July 11, 2006. Male patient was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased. TRILEPTAL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported TRILEPTAL problem on Aug 07, 2006. Male patient, 77 years of age, was diagnosed with spinal column stenosis and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: confusional state, mental impairment, stomach discomfort, therapeutic response unexpected. TRILEPTAL dosage: 125 MG BID UNK. During the same period patient was treated with COUMADIN, ENALAPRIL. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Sept 08, 2006. Female patient was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, pyrexia, rash. TRILEPTAL dosage: 300 MG BID UNK ; 600 MG BID UNK. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Aug 09, 2006. Female patient, 47 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: weight increased. TRILEPTAL dosage: 900 MG QD ORAL. Patient recovered.

TRILEPTAL problem was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Female patient, 22 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: weight increased. TRILEPTAL dosage: 300 MG BID ; 450 MG BID ; 450 G QAM + 600 MG QPM,. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Aug 30, 2006. Female patient, 59 years of age, weighting 1700 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: confusional state, dizziness, fatigue, mood altered, nausea, sinus disorder. TRILEPTAL dosage: unknown. During the same period patient was treated with NEXIUM, KEPPRA. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Female patient, child 6 years of age, weighting 49.38 lb, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: fall, grand mal convulsion, head injury, headache, hyponatraemia, skin swelling, tremor, vomiting. TRILEPTAL dosage: 300 MG QAM + 450 MG QPM, ORAL. During the same period patient was treated with ELOCON, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Oct 03, 2006. Male patient, child 3 years of age, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, status epilepticus. TRILEPTAL dosage: 300 MG, BID, ORAL. During the same period patient was treated with DEPAKOTE, LAMICTAL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Female patient, 42 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: alopecia, malaise, nausea, stomach discomfort. TRILEPTAL dosage: 300 MG, BID. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Oct 09, 2006. Female patient, 79 years of age, weighting 160.1 lb, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: bedridden, confusional state, decreased activity, hyponatraemia. TRILEPTAL dosage: 600 MG, BID, ORAL. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Dec 12, 2006. Male patient, 49 years of age, was diagnosed with trigeminal neuralgia and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. TRILEPTAL dosage: unknown. During the same period patient was treated with DEPAKOTE, BETASERON, TRICOR, NEXIUM, CARDIZEM CD, BENICAR, LIVITRA, LISINOPRIL. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on July 19, 2006. Female patient was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. TRILEPTAL dosage: 450 MG, BID, ORAL. During the same period patient was treated with NEURONTIN. Patient recovered.

TRILEPTAL problem was reported by a Pharmacist from UNITED STATES on June 01, 2006. Male patient, 32 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: neutropenia. TRILEPTAL dosage: 1200 MG, QD. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported TRILEPTAL problem on June 02, 2006. Female patient was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion. TRILEPTAL dosage: 900 MG QAM + 1200 MG QHS, ORAL. During the same period patient was treated with TOPAMAX. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on June 05, 2006. Male patient, 31 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. TRILEPTAL dosage: 1800 MG, QD, ORAL. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on June 06, 2006. Male patient, child 12 years of age, weighting 63.05 lb, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, lethargy, status epilepticus. TRILEPTAL dosage: 1050 MG, QD. During the same period patient was treated with LAMICTAL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on June 12, 2006. Male patient, weighting 175.0 lb, was diagnosed with tonic convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. TRILEPTAL dosage: 900 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on July 05, 2006. Male patient, 35 years of age, weighting 167.6 lb, was diagnosed with astrocytoma and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: cellulitis, erythema multiforme, pruritus, skin exfoliation, skin lesion. TRILEPTAL dosage: unknown. During the same period patient was treated with TEMODAR, BACTRIM, REGLAN, DILANTIN KAPSEAL, PREDNISONE, BENADRYL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2006. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: thyroxine decreased. TRILEPTAL dosage: unknown. During the same period patient was treated with TRAZODONE, LEXAPRO. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Mar 13, 2006. Female patient, 28 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: rash. TRILEPTAL dosage: 150 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Mar 14, 2006. Female patient, child 6 years of age, weighting 52.03 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic enzyme increased, urticaria. TRILEPTAL dosage: 150 MG AM, 300 MG PM. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Apr 07, 2006. Male patient, 56 years of age, weighting 170.0 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: amnesia. TRILEPTAL dosage: 600 MG, BID, ORAL. During the same period patient was treated with LAMICTAL, SYNTHROID, LYRICA. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2006. Male patient was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, dizziness, fatigue, hypertension. TRILEPTAL dosage: 900 MG, BID. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Mar 14, 2006. Female patient, 68 years of age, was diagnosed with complex partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, erythema, pruritus. TRILEPTAL dosage: 1200 MG, QD, ORAL. During the same period patient was treated with ZONEGRAN, ATENOLOL, PROTONIX, BREVA, RIBAVIRIN, NIFEDICAL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Apr 25, 2006. Female patient, 17 years of age, weighting 130.1 lb, was diagnosed with bipolar disorder, infectious mononucleosis, pharyngeal oedema and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, disturbance in attention, dizziness, middle insomnia, pneumonia, tremor. TRILEPTAL dosage: unknown. During the same period patient was treated with BIAXIN, LEVAQUIN, PREDNISOLONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Mar 20, 2006. Female patient, 45 years of age, was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: amnesia, clumsiness, expressive language disorder. TRILEPTAL dosage: 600 MG, TID, ORAL. During the same period patient was treated with EFFEXOR, KLONOPIN. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Apr 11, 2006. Male patient, child 11 years of age, weighting 5.95 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, lymphadenopathy, pyrexia, rash. TRILEPTAL dosage: 600 MG, BID, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on May 16, 2006. Female patient, 51 years of age, was diagnosed with bipolar disorder, fluid retention and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, mood altered, swelling. TRILEPTAL dosage: 300 MG, BID, ORAL, 150 MG, BID, ORAL, 150 MG, QD, ORAL, 300 MG, BID ORAL. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ATENOLOL, ATACAND, PAXIL, ALPRAZOLAM. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Apr 05, 2006. Female patient, child 8 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, hyponatraemia. TRILEPTAL dosage: 22 MG / KG, QD. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Apr 04, 2006. Male patient was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, hyponatraemia. TRILEPTAL dosage: 1800 MG, QD. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Health Professional from UNITED STATES on Apr 10, 2006. Female patient, 23 years of age, was diagnosed with grand mal convulsion, depression and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: increased tendency to bruise, platelet count decreased. TRILEPTAL dosage: 300 MG, BID. During the same period patient was treated with LEXAPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported TRILEPTAL problem on Apr 10, 2006. Female patient, 50 years of age, weighting 235.0 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hunger, weight increased. TRILEPTAL dosage: 300 MG -- 2 QAM + 3 QHS. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Apr 17, 2006. Female patient, child 7 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: status epilepticus. TRILEPTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on July 24, 2006. Female patient, 44 years of age, was diagnosed with affective disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, affect lability, dizziness postural, panic attack. TRILEPTAL dosage: 150 MG, BID, ORAL. During the same period patient was treated with LISINOPRIL, NORVASC, HYDROCHLOROTHIAZIDE, PROPRANOLOL, PRILOSEC, ZETIA, ALLEGRA, ALBUTEROL. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Female patient was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: erythema, skin discolouration, skin necrosis, skin reaction, systemic lupus erythematosus. TRILEPTAL dosage: 600 MG, TID, ORAL. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on May 02, 2006. Male patient, 21 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: agitation, anger, irritability, mania. TRILEPTAL dosage: 900 MG, BID, ORAL. During the same period patient was treated with GEODON, LITHIUM CARBONATE, DEPAKOTE, RISPERIDONE. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Feb 24, 2006. Female patient, 13 years of age, weighting 90.39 lb, was diagnosed with partial seizures and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hypersensitivity, pharyngolaryngeal pain, rash, swelling face. TRILEPTAL dosage: 300 MG, BID, ORAL. During the same period patient was treated with TEGRETOL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on July 19, 2006. Male patient, child 12 years of age, weighting 89.95 lb, was diagnosed with affective disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, biopsy skin abnormal, blister, c-reactive protein increased, cellulitis, chills, conjunctivitis, constipation. TRILEPTAL dosage: 1/2 TABLET 450 MG/BID, ORAL. During the same period patient was treated with ADDERALL, DEPAKOTE, BUSPAR. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2006. Female patient was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: abdominal distension, fluid retention, weight increased. TRILEPTAL dosage: unknown. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Feb 15, 2006. Female patient, 46 years of age, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: dizziness, gait disturbance, grand mal convulsion, respiratory arrest, tremor. TRILEPTAL dosage: 300 MG, BID, ORAL. During the same period patient was treated with NEURONTIN. Patient was hospitalized. Patient recovered.

TRILEPTAL problem was reported by a Physician from UNITED STATES on Apr 06, 2006. Male patient, child 6 years of age, weighting 44.97 lb, was diagnosed with convulsion and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: convulsion, muscle contractions involuntary. TRILEPTAL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported TRILEPTAL problem on Apr 06, 2006. Male patient, child 6 years of age, weighting 44.09 lb, was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: drop attacks, petit mal epilepsy. TRILEPTAL dosage: 300 MG, BID, ORAL. Patient recovered.

Showing 1-75 of 438 Next >

Ask Our Patient Community about TRILEPTAL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B